Background: Rheumatoid arthritis has seen a significant increase in both incidence and prevalence 9 and its treatments show limited efficiency due to their undesirable effects on patient health. 10 Therefore, major interests lie in the development of treatments with drugs derived from plants or 11 other natural sources with little adverse effects as an alternative to current treatments. 12
Anti-inflammatory properties of natural ingredients used in combinations on adjuvant induced
Rheumatoid arthritis is an inflammatory autoimmune disorder. Its incidence and prevalence 44 increase considerably all over the world. In North America and North-European countries, its 45 incidence varies between 20 and 50 per 100,000 population (Fazal et al., 2018 
)). 63
GS is an important component of cartilage and is naturally synthesized in the body. This amino 64 monosaccharide stimulates the biosynthesis of glycosaminoglycan chains, giving the cartilage its 65 strength, flexibility and elasticity, all the while possessing anti-inflammatory properties (Singh et 66 al., 2007) . HA is a large viscoelastic glycosaminoglycan present in the synovial fluid, and is 67 responsible for its viscoelastic properties (Moreland, 2003) . It also confers good protective 68 properties including shock absorption, protective coating of the articular cartilage surface, and 69 lubrication. BS and SA have both anti-inflammatory and analgesic properties due to the presence 70 of boswellic acid and salicin respectively (Kimmatkar et al., 2003; Shara and Stohs, 2015) .
71
Boswellic acid reduces pain and swelling, has antioxidant and free radical-scavenging properties, 72 and appears as a potential new treatment of inflammatory disorders like rheumatoid arthritis and 73 osteoarthritis (Umar et al., 2014) . It reduces glycosaminoglycan degradation, keeping the cartilage 74 in good condition unlike NSAIDs that can induce the disruption of the glycosaminoglycan 75 synthesis, accelerating articular damage (Kimmatkar et al., 2003) . Salicin has anti-inflammatory 76 and anabolic effects, as shown in canine joints (Shara and Stohs, 2015) . Benefits of these natural 77 ingredients have so far only been studied separately, and their potential synergistic effects need to 78 be assessed, as a combination of ingredients can improve their therapeutic effects at the low doses 79 recommended by the health regulation agencies. 80
Thus, the aim of this study is to examine the potency of different combinations of natural 81 ingredients to limit arthritis symptoms and articular inflammation on an animal model of 82 rheumatoid arthritis. were targeted: interleukin-1 (IL-1β), interleukin-17 (IL-17A) and tumor necrosis factor (TNF-α).
149
Primer sequences used for amplification are shown in Table 2 . and were purchased from Sigma 150 Aldrich (Oakville, Ontario, Canada). Gene expression was quantified by Cycle Treshold method 151 (Ct). Amplification standard curve of each gene was performed and the specific amplification 152 efficiency was verified with a minimal threshold of 1,8 (maximum 2). In order to standardize and 153 compare the different assays, a pool of cDNAs of all groups was used as an internal calibrator.
154
Gene quantification values were expressed relative to the gene quantification of two endogenous 155 references, β-actin and glyceraldehyde 3-phosphate dehydrogenase (GAPDH). Ratio expressions 156 for both references were similar; only results with the expression of β-actin are shown in this study.
157
The specificity of PCR products was confirmed by migration on electrophoresis gel and melting 158 curve analysis. 
Statistical Analysis 164
The results are shown as mean ± standard errors. They were analyzed using JMP Pro (SAS, Cary, 165 NC, USA). One-way ANOVAs followed by a Tukey's test were used to determine if there were 166 differences between groups. The homogeneity of variance and the normality of data were tested 167 using a Shapiro-Wilk and Bartlett's test respectively. Two groups were statistically different if the 168 p-value is lower than 0,05 169
Results 171

Effect on Clinical Signs of Arthritis 172
Measurement of hind-paw thickness and evaluation of the arthritis scores quantified the 173 development of clinical symptoms in rats during the experiment. First signs of arthritis appeared 174 on day 12 after the injection of Freund's adjuvant (Fig. 2) hind-paw conditions of each group at the end of the experiment are shown in Fig. 3 . 192
Effect on Expression of Pro-inflammatory and Cartilage Degradation Genes 193
At day 29, expression of cytokines IL-17A and IL-1β of CFA group was significantly greater than 194 the control group (Fig. 4A-B) . Glu+Hyal A+Sal treatment significantly reduced the expression of 195 IL-17A and IL-1β compared to the CFA group. A decrease in the expression of IL-17A by 196
Glu+Bosw and Glu+Bosw+Sal was also noticed. Glu+Hyal A+Bosw tended to limit IL-17A and 197 IL-1β expressions, but the difference with the CFA group wasn't significant. TNF-α expression of 198 CFA group was not superior to the control group (Fig 4C) . Glu+Hyal A+Sal treatment inhibited 199 TNF-α compared to both the control and the CFA group. 200
Effect on Total Antioxidant Activity of Plasma 201 The aim of this study was to evaluate if glucosamine sulfates therapeutic effects against rheumatoid 209 arthritis could be enhanced through a combination with hyaluronic acid, Boswellia serrata extract 210 or Salix alba extract. First symptoms of arthritis were evaluated by measuring the thickness of hind 211 paws and by a visual examination (arthritis score). The combinations with BS and/or SA 212 significantly reduce hind-paw thickness and arthritis scores during the treatment. Salix nigra bark 213 methanol extract (100 mg/kg/day) has inhibited the progression of collagen-induced arthritis in rats 214 at the end of the experiment by leaving arthritis scores and paw swelling close to healthy control 215 (Sharma et al., 2011) . In other studies, boswellic acid extract (total acid content: 93 ± 3%) from BS 216 (250 mg/kg) was more efficient than glucosamine (250 mg/kg) to reduce inflammation in 217
Mycobacterium-induced arthritis in acute and chronic model of inflammation in rats (Singh et al., 218
2007). Furthermore, in the same study, the combination of these two ingredients have shown a 219 significant synergistic effect on chronic inflammation with a dose of 125 mg/kg for boswellic acid 220 and 125 mg/kg for glucosamine. We suspect that the synergistic effect result from the combination 221 of the different metabolic targets by which the bioactive molecules reduce inflammation. Anti-222 arthritic proprieties of each ingredient might have amplified the therapeutic effect of treatments.
223
Glucosamine and hyaluronic acid have major structural roles in articular cartilage. Glucosamine 224 stimulates the production of glycosaminoglycans that provide strength and elasticity to cartilage previous study demonstrated that glucosamine can inhibit swelling in joints and reduce arthritic 239 scores in rat adjuvant arthritis (Hua et al., 2005) . However, the dose that they used was much higher 240 than the equivalent dose usually administered to humans. It happens frequently in animal studies 241 that the administered dose is higher than the recommended equivalent (when corrected for 242 allometry) for humans. These doses could not be applied to humans according to the severe 243 legislation in different countries. Maximal dosages of natural products are highly regulated to avoid 244 adverse effects. We can therefore suspect that maximal recommended dosages for humans may not 245 result in significant inhibition of the clinical signs of arthritis in both rats and humans. For example, 246 a meta-analysis including 10 trials with an average of at least 100 patients concluded that 247 glucosamine (1500 mg/kg/day: recommended dosage) was not effective against osteoarthritis, 248 having no relevant clinical effect on pain or structure of affected joints (Wandel et al., 2010) . Then, 249
it becomes clearly advantageous to use combinations of ingredients to compensate for the small 250 effect of a single ingredient (at recommended doses), and to rely on the synergetic effect of 251 combinations without exceeding the recommended dosages of individual biomolecules. 252
Inhibition of pro-inflammatory cytokines can reduce clinical signs of arthritis. We therefore 253
analyzed the mRNA content of three pro-inflammatory cytokines. IL-1β and TNF-α, two major 254 pro-inflammatory cytokines, are both known to be present at high concentrations in serum and 255 synovial fluid in patients with RA (Umar et al., 2014) . IL-1β and TNF-α stimulate their own 256 production and the production of other cytokines, amplifying the inflammation process (Moreland, 257 2003) and contribute synergistically to produce the inflammasome (Gaffen, 2009) . 258
In our study, TNF-α and IL-1β expression was significantly reduced by only Glu+Hyal A+Sal. A 259 previous study, on synovial-cell cultures from patients with RA, demonstrated that blocking the 260 activity of TNF-α significantly reduced the production of IL-1, IL-6 and IL-8 (Butler et al., 1995) . 261
Thus, blocking TNF-α may have a greater overall effect on inflammation than only blocking IL-1. 262
Moreover, we suspect that this reduction of TNF-α partly results from SA activity. In a recent 263 review, Shara and Stohs (2015) came to the conclusion that the anti-inflammatory activity of SA is 264 associated with down regulation of the pro-inflammatory effect of TNF-α. In addition to salicin, 265 SA has other active compounds like polyphenols and flavonoids which may also play a role in the 266 therapeutic action of SA (Dragos et al., 2017) . On the other hand, HA didn't seem to have any 267 impact on the level of TNF-α in RA rats. Injection of intra-articular HA in rat antigen-induced 268 arthritis did show no significant changes in the level of TNF-α in short-term and in long-term 269 experiments (Roth et al., 2005) . Thus, we suspect that SA has an important role in the anti-270 inflammatory properties of a Glu+Hyal A+Sal treatment. 271
At the end of the experiment, three treatments containing BS and/or SA were able to inhibit IL-17A 272 expression compared to TNF-α that was only inhibited by Glu+Hyal A+Sal. Furthermore, we did 273 not observe a difference in the level of TNF-α expression between the control and CFA group.
274
These results suggest that TNF-α had a weaker role in chronic inflammation than IL-17A, at least 275 at the sampling periods of our experimentation. IL-17A is also over-expressed in RA (Dudler et al., 276 2000) . It has been shown that TNF-α may be important in the onset of the arthritis induction, but it 277 gradually loses its dominance with the progression of the inflammation (Joosten et al., 1996) . They 278
showed that anti-TNFα treatment was efficient shortly after the collagen-induced arthritis (CIA) in 279 DBA/1 mice, reducing cartilage destruction, but that it had little effect when CIA is fully 280 established (Joosten et al., 1996) . To notice a difference in TNF-α levels, measurements should 281 have then been performed at the beginning of the inflammatory phase. We suggest that TNF-α 282 played a lesser role in the late phase of our experiment and had lower involvement in inflammatory 283 modulation than IL-1β and IL-17A. 284
As mentioned previously, our treatments had a stronger impact on IL-17A expression than in the 285 expression of the two other cytokines. IL-17 is involved in inflammation by stimulating other pro-286 inflammatory cytokines and metalloproteinases in synoviocytes and chondrocytes (Dudler et two have many overlapping responses and functions even if they are not from the same cytokine 296 family, as shown in SCW-induced arthritis and IL-1-deficient mice (Koenders et al., 2005) . We 297 conclude that IL-17A might partly lead the inflammatory process at the end of our experimental 298 arthritis and that treatments with plants were effective to decrease the expression of this cytokine. 299
Anti-inflammatory properties of BS and SA successfully reduced the IL-17A effect according to 300 our results. 301
Reactive oxygen species (ROS) can also contribute to matrix component degradation (Campo et 302 al., 2008) . ROS are generated at high rates in synovial neutrophils from RA patients (Sato et al., 303 1988) . Synovial fluid and HA are respectively susceptible to degradation and depolymerization by 304 a high level of ROS (Sato et al., 1988) . These processes promote loss of viscosity in the joint as 305 well as osteoclast activation (Filippin et al., 2008) . Different antioxidants (polyphenols, tannins, 306 etc.) are found in natural ingredients (Sato et al., 1988) which have been reported to partly protect 307 and limit damage to cartilage (Venkatesha et al., 2011) . All combinations with HA, BS and/or SA 308 have significantly increased the total antioxidant level in the plasma of our experimental rats.
309
Combinations without SA appear to have more impact on antioxidant levels than those with SA. In 310 a previous study, it has been demonstrated that CIA in rats increases the activity of three important 311 enzymes involved in oxidative stress management in plasma: superoxide dismutase, glutathione 312 peroxidase and catalase (Sharma et al., 2011) . They showed that these enzymes respond naturally 313 to a higher concentration of ROS after arthritis induction, increasing their activities to protect 314 tissues in the joint. CFA groups: n = 10-11; Glu: n = 9-10; Glu+Hyal A, Glu+Hyal A+Bosw, Glu+Hyal A+Sal, 457
Glu+Bosw and Glu+Bosw+Sal: n = 5-6). Significant differences with CFA group (*) and control 458 group (+) at day 29 are shown (p < 0.05). 
